9KS-22635-45879
2 vaccinations
3 coded responses
21 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 451 / OH
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Dose 1 — Pfizer-BioNTech
-
2021-02-28
Registered in v-safe
- 2021-02-28
- 2021-03-01
- 2021-03-02
-
2021-03-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-03-04
-
2021-03-11
Survey response — day 14, dose 1MedDRA: Migraine — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Migraine symptoms- most likely unrelatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Dose 2 — Pfizer-BioNTech
-
2021-03-18
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
- 2021-04-11
- 2021-04-15
- 2021-04-28
- 2021-04-29
-
2021-06-17
Survey response — 3 months, dose 2MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy · Healthcare visit (other): OBGYNMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-17
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-19
-
2021-09-16
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Coldlike symptoms- tested negative for covidMedDRA releases: 2024-11 · check-in free text available
-
2021-09-16
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | |
| 2 | 2021-03-18 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
Free text
Release 5 — day 14, dose 1
Symptoms: Migraine symptoms- most likely unrelated
Release 9 — 3 months, dose 2
Release 9 — 6 months, dose 2
Symptoms: Coldlike symptoms- tested negative for covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release